Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
Pick Your Favored kind of books- Avoid Slam: Clearing the Street for the Eventual fate of Standard Size Trucks
- Parents speak out as 4-year-old fights button battery injury in intensive care unit
- Banks for High Fixed Store Rates: Augment Your Investment funds
- The most effective method to Involve Handshakes for Compromise and Compromise
- 'It's doing badly': Fears grow for whale stuck off Germany's coast
- Manual for Financial plan Agreeable PC
- What's going around right now? COVID, flu, stomach bug on the rise
- Japan prepares to restart world's biggest nuclear plant, 15 years after Fukushima
